Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review.

Abstract

BACKGROUND The use of mycophenolate mofetil (MMF) as a primary immunosuppressant after transplantation is increasing. A number of factors interact to result in variability in blood levels of mycophenolic acid (MPA) increasing the risk of toxicity. This has led to interest in the application of therapeutic drug monitoring to optimize its use. METHODS A… (More)
DOI: 10.1097/TP.0b013e3181744199

Topics

Cite this paper

@article{Knight2008DoesTE, title={Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review.}, author={Simon R Knight and Peter J. Morris}, journal={Transplantation}, year={2008}, volume={85 12}, pages={1675-85} }